Skip to search formSkip to main contentSkip to account menu

Livagen

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Oligopeptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
[Genomic instability in atherosclerosis].
A comparative study of the level of genomic instability, parameters of quantitative and structural mutations of chromosomes… 
2014
2014
[Effect of peptide bioregulator and cobalt ions on the activity of NORs and associations of acrocentric chromosomes in lymphocytes of patients with hypertrophic cardiomyopathy and their relatives].
The influence of peptide bioregulator - Livagen (Lys-Glu-Asp-Ala) separately and combined with cobalt ions, on the activity of… 
2008
2008
[The effect of heavy metal ions and peptide bioregulators on the expression of chromosome fragile sites in the individuals of different age groups and breast cancer patients].
Expression rates of chromosome fragile sites in peripheral blood lymphocytes have been studied in clinically healthy individuals… 
2007
2007
[Variability of radiation-induced adaptive response in old age individuals and their correction by Peptide bioregulator -Livagen].
Effect of aging on adaptive response of cellular systems to low (stimulated) dozes of gamma-rays (0, 2 and 0, 5 Gy) and to… 
2005
2005
[Effect of peptide Livagen on activity of digestive enzymes in gastrointestinal tract and non-digestive organs in rats of different ages].
It is stated that Livagen (Lys-Glu-Asp-Ala) is a weakly hydrolyzed peptide. Peptide hydrolases of small intestine do not…